International Journal of Current Pharmaceutical Review and Research 2026
Top Research Directions
The 2 research directions with International Journal of Current Pharmaceutical Review and Research 2026 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.
| # | Direction | Papers | Share |
|---|---|---|---|
| 1 | Anticipating Organ Injury Before Functional Decline | 1 | 100.0% |
| 2 | Reducing Diagnostic Latency in Infectious Disease Identification | 1 | 100.0% |
Download all directions as CSV
Institutions
Institutions credited by International Journal of Current Pharmaceutical Review and Research 2026 papers: a paper credits every institution named in its affiliations, once. 1 institutions share 1 credited papers.
| # | Institution | Papers | Share |
|---|---|---|---|
| 1 | Gandhi Medical College | 1 | 100.0% |
Download all institutions as CSV
About this data
Papers. International Journal of Current Pharmaceutical Review and Research 2026 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.
Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.
Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.
Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “International Journal of Current Pharmaceutical Review and Research 2026”, https://lacuna.tiptreesystems.com/venue/international-journal-of-current-pharmaceutical-review/2026.
Papers
| Title |
|---|
| Comparative Assessment of Systemic Inflammatory Response Between Drug-Sensitive and Rifampicin-Resistant Pulmonary Tuberculosis Under NTEP Guidelines |